カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

胃腸薬の世界市場2022：処方胃腸薬、OTC胃腸薬

■ 英語タイトル：Global Gastrointestinal Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3808）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3808
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[胃腸薬の世界市場2022：処方胃腸薬、OTC胃腸薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の胃腸薬市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の胃腸薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

胃腸薬市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・処方胃腸薬、OTC胃腸薬

アプリケーション別セグメントは次のように区分されます。
・慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他

世界の胃腸薬市場の主要な市場プレーヤーは以下のとおりです。
・AstraZeneca、Sanofi、Bayer、Pfizer、GlaxoSmithKline、Teva、Zeria (Tillotts)、Perrigo、Boehringer Ingelheim、Purdue Pharma、C.B. Fleet、Abbott、Jiangzhong、Xian-Janssen

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、胃腸薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な胃腸薬メーカーの企業概要、2019年～2022年までの胃腸薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な胃腸薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別胃腸薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの胃腸薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での胃腸薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および胃腸薬の産業チェーンを掲載しています。
・第13、14、15章では、胃腸薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 胃腸薬の概要
– 種類別分析（2017年vs2021年vs2028年）：処方胃腸薬、OTC胃腸薬
– 用途別分析（2017年vs2021年vs2028年）：慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他
– 世界の胃腸薬市場規模・予測
– 世界の胃腸薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AstraZeneca、Sanofi、Bayer、Pfizer、GlaxoSmithKline、Teva、Zeria (Tillotts)、Perrigo、Boehringer Ingelheim、Purdue Pharma、C.B. Fleet、Abbott、Jiangzhong、Xian-Janssen
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：処方胃腸薬、OTC胃腸薬
・用途別分析2017年-2028年：慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他
・胃腸薬の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・胃腸薬のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・胃腸薬のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・胃腸薬の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・胃腸薬の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Gastrointestinal Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastrointestinal Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastrointestinal Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market Size & Forecast
1.4.1 Global Gastrointestinal Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gastrointestinal Drugs Sales in Volume (2017-2028)
1.4.3 Global Gastrointestinal Drugs Price (2017-2028)
1.5 Global Gastrointestinal Drugs Production Capacity Analysis
1.5.1 Global Gastrointestinal Drugs Total Production Capacity (2017-2028)
1.5.2 Global Gastrointestinal Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastrointestinal Drugs Market Drivers
1.6.2 Gastrointestinal Drugs Market Restraints
1.6.3 Gastrointestinal Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Gastrointestinal Drugs Product and Services
2.1.4 AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Gastrointestinal Drugs Product and Services
2.2.4 Sanofi Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Gastrointestinal Drugs Product and Services
2.3.4 Bayer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Gastrointestinal Drugs Product and Services
2.4.4 Pfizer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Gastrointestinal Drugs Product and Services
2.5.4 GlaxoSmithKline Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Gastrointestinal Drugs Product and Services
2.6.4 Teva Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zeria (Tillotts)
2.7.1 Zeria (Tillotts) Details
2.7.2 Zeria (Tillotts) Major Business
2.7.3 Zeria (Tillotts) Gastrointestinal Drugs Product and Services
2.7.4 Zeria (Tillotts) Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Perrigo
2.8.1 Perrigo Details
2.8.2 Perrigo Major Business
2.8.3 Perrigo Gastrointestinal Drugs Product and Services
2.8.4 Perrigo Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Gastrointestinal Drugs Product and Services
2.9.4 Boehringer Ingelheim Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Purdue Pharma
2.10.1 Purdue Pharma Details
2.10.2 Purdue Pharma Major Business
2.10.3 Purdue Pharma Gastrointestinal Drugs Product and Services
2.10.4 Purdue Pharma Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 C.B. Fleet
2.11.1 C.B. Fleet Details
2.11.2 C.B. Fleet Major Business
2.11.3 C.B. Fleet Gastrointestinal Drugs Product and Services
2.11.4 C.B. Fleet Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Abbott
2.12.1 Abbott Details
2.12.2 Abbott Major Business
2.12.3 Abbott Gastrointestinal Drugs Product and Services
2.12.4 Abbott Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Jiangzhong
2.13.1 Jiangzhong Details
2.13.2 Jiangzhong Major Business
2.13.3 Jiangzhong Gastrointestinal Drugs Product and Services
2.13.4 Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Xian-Janssen
2.14.1 Xian-Janssen Details
2.14.2 Xian-Janssen Major Business
2.14.3 Xian-Janssen Gastrointestinal Drugs Product and Services
2.14.4 Xian-Janssen Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gastrointestinal Drugs Breakdown Data by Manufacturer
3.1 Global Gastrointestinal Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gastrointestinal Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gastrointestinal Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gastrointestinal Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Gastrointestinal Drugs Manufacturer Market Share in 2021
3.5 Global Gastrointestinal Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gastrointestinal Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gastrointestinal Drugs Market Size by Region
4.1.1 Global Gastrointestinal Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Gastrointestinal Drugs Revenue by Region (2017-2028)
4.2 North America Gastrointestinal Drugs Revenue (2017-2028)
4.3 Europe Gastrointestinal Drugs Revenue (2017-2028)
4.4 Asia-Pacific Gastrointestinal Drugs Revenue (2017-2028)
4.5 South America Gastrointestinal Drugs Revenue (2017-2028)
4.6 Middle East and Africa Gastrointestinal Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gastrointestinal Drugs Sales in Volume by Type (2017-2028)
5.2 Global Gastrointestinal Drugs Revenue by Type (2017-2028)
5.3 Global Gastrointestinal Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gastrointestinal Drugs Sales in Volume by Application (2017-2028)
6.2 Global Gastrointestinal Drugs Revenue by Application (2017-2028)
6.3 Global Gastrointestinal Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gastrointestinal Drugs Sales by Type (2017-2028)
7.2 North America Gastrointestinal Drugs Sales by Application (2017-2028)
7.3 North America Gastrointestinal Drugs Market Size by Country
7.3.1 North America Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Gastrointestinal Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gastrointestinal Drugs Sales by Type (2017-2028)
8.2 Europe Gastrointestinal Drugs Sales by Application (2017-2028)
8.3 Europe Gastrointestinal Drugs Market Size by Country
8.3.1 Europe Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Gastrointestinal Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gastrointestinal Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Gastrointestinal Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Gastrointestinal Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gastrointestinal Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gastrointestinal Drugs Sales by Type (2017-2028)
10.2 South America Gastrointestinal Drugs Sales by Application (2017-2028)
10.3 South America Gastrointestinal Drugs Market Size by Country
10.3.1 South America Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Gastrointestinal Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gastrointestinal Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Gastrointestinal Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Gastrointestinal Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gastrointestinal Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gastrointestinal Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gastrointestinal Drugs
12.3 Gastrointestinal Drugs Production Process
12.4 Gastrointestinal Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gastrointestinal Drugs Typical Distributors
13.3 Gastrointestinal Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Gastrointestinal Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gastrointestinal Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Gastrointestinal Drugs Product and Services
Table 6. AstraZeneca Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Gastrointestinal Drugs Product and Services
Table 10. Sanofi Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Gastrointestinal Drugs Product and Services
Table 14. Bayer Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Gastrointestinal Drugs Product and Services
Table 18. Pfizer Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Gastrointestinal Drugs Product and Services
Table 22. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Teva Basic Information, Manufacturing Base and Competitors
Table 24. Teva Major Business
Table 25. Teva Gastrointestinal Drugs Product and Services
Table 26. Teva Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zeria (Tillotts) Basic Information, Manufacturing Base and Competitors
Table 28. Zeria (Tillotts) Major Business
Table 29. Zeria (Tillotts) Gastrointestinal Drugs Product and Services
Table 30. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Perrigo Basic Information, Manufacturing Base and Competitors
Table 32. Perrigo Major Business
Table 33. Perrigo Gastrointestinal Drugs Product and Services
Table 34. Perrigo Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 36. Boehringer Ingelheim Major Business
Table 37. Boehringer Ingelheim Gastrointestinal Drugs Product and Services
Table 38. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Purdue Pharma Major Business
Table 41. Purdue Pharma Gastrointestinal Drugs Product and Services
Table 42. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. C.B. Fleet Basic Information, Manufacturing Base and Competitors
Table 44. C.B. Fleet Major Business
Table 45. C.B. Fleet Gastrointestinal Drugs Product and Services
Table 46. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Abbott Basic Information, Manufacturing Base and Competitors
Table 48. Abbott Major Business
Table 49. Abbott Gastrointestinal Drugs Product and Services
Table 50. Abbott Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Jiangzhong Basic Information, Manufacturing Base and Competitors
Table 52. Jiangzhong Major Business
Table 53. Jiangzhong Gastrointestinal Drugs Product and Services
Table 54. Jiangzhong Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Xian-Janssen Basic Information, Manufacturing Base and Competitors
Table 56. Xian-Janssen Major Business
Table 57. Xian-Janssen Gastrointestinal Drugs Product and Services
Table 58. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Gastrointestinal Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Gastrointestinal Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Gastrointestinal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Gastrointestinal Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Gastrointestinal Drugs Production Site of Key Manufacturer
Table 64. Gastrointestinal Drugs New Entrant and Capacity Expansion Plans
Table 65. Gastrointestinal Drugs Mergers & Acquisitions in the Past Five Years
Table 66. Global Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
Table 67. Global Gastrointestinal Drugs Sales by Region (2023-2028) & (K Units)
Table 68. Global Gastrointestinal Drugs Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Gastrointestinal Drugs Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Global Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Global Gastrointestinal Drugs Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Gastrointestinal Drugs Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Gastrointestinal Drugs Price by Type (2017-2022) & (USD/Unit)
Table 75. Global Gastrointestinal Drugs Price by Type (2023-2028) & (USD/Unit)
Table 76. Global Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Global Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Global Gastrointestinal Drugs Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Gastrointestinal Drugs Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Gastrointestinal Drugs Price by Application (2017-2022) & (USD/Unit)
Table 81. Global Gastrointestinal Drugs Price by Application (2023-2028) & (USD/Unit)
Table 82. North America Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 83. North America Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
Table 84. North America Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 87. North America Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 88. North America Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 89. North America Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Europe Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 91. Europe Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
Table 92. Europe Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Europe Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Europe Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Europe Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Gastrointestinal Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Gastrointestinal Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Gastrointestinal Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 106. South America Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 107. South America Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
Table 108. South America Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 111. South America Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 112. South America Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 113. South America Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Gastrointestinal Drugs Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Gastrointestinal Drugs Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Gastrointestinal Drugs Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Gastrointestinal Drugs Raw Material
Table 123. Key Manufacturers of Gastrointestinal Drugs Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Gastrointestinal Drugs Typical Distributors
Table 127. Gastrointestinal Drugs Typical Customers
List of Figures
Figure 1. Gastrointestinal Drugs Picture
Figure 2. Global Gastrointestinal Drugs Revenue Market Share by Type in 2021
Figure 3. Prescription Gastrointestinal Drug
Figure 4. OTC Gastrointestinal Drug
Figure 5. Global Gastrointestinal Drugs Revenue Market Share by Application in 2021
Figure 6. Chronic Gastritis
Figure 7. Functional Dyspepsia
Figure 8. Peptic Ulcer
Figure 9. Acute Gastroenteritis
Figure 10. Other
Figure 11. Global Gastrointestinal Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Gastrointestinal Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Gastrointestinal Drugs Sales (2017-2028) & (K Units)
Figure 14. Global Gastrointestinal Drugs Price (2017-2028) & (USD/Unit)
Figure 15. Global Gastrointestinal Drugs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Gastrointestinal Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Gastrointestinal Drugs Market Drivers
Figure 18. Gastrointestinal Drugs Market Restraints
Figure 19. Gastrointestinal Drugs Market Trends
Figure 20. Global Gastrointestinal Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Gastrointestinal Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Gastrointestinal Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Gastrointestinal Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Gastrointestinal Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Gastrointestinal Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Gastrointestinal Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Gastrointestinal Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Gastrointestinal Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Gastrointestinal Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Gastrointestinal Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Gastrointestinal Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Gastrointestinal Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Gastrointestinal Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Gastrointestinal Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Gastrointestinal Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Gastrointestinal Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Gastrointestinal Drugs in 2021
Figure 79. Manufacturing Process Analysis of Gastrointestinal Drugs
Figure 80. Gastrointestinal Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 消化器内視鏡検査機器の世界市場2022：軟性内視鏡、カプセル内視鏡
  • 抗がん剤の世界市場2022：化学療法、標的療法、免疫療法、ホルモン療法（生物療法）、その他
  • 血液疾患治療薬の世界市場2022：OTC、Rxドラッグ
  • 血液学用医薬品の世界市場2022：OTC、Rxドラッグ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3808 )"胃腸薬の世界市場2022：処方胃腸薬、OTC胃腸薬" (英文：Global Gastrointestinal Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。